MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MedPage Today Meeting Coverage' source. Wed, 08 Feb 2012 18:50:29 +0100 http://www.medworm.com/index.php?rid=5668481&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSCCM%2F31089 HOUSTON (MedPage Today) -- Pre-hospital steroid therapy did not reduce the risk of acute lung injury in critically ill patients and might have increased inhospital mortality risk, according to a study reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5668481 Wed, 08 Feb 2012 22:13:06 +0100 5668481 http://www.medworm.com/index.php?rid=5660761&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASAMeeting%2F31026 NEW ORLEANS (MedPage Today) -- A newer cerebral revascularization device not yet approved in the U.S. outperformed the FDA-approved Merci retriever, a randomized trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5660761 Sun, 05 Feb 2012 20:19:09 +0100 5660761 http://www.medworm.com/index.php?rid=5660762&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASAMeeting%2F31025 NEW ORLEANS (MedPage Today) -- Reducing the size of an intracerebral hemorrhage through a minimally invasive surgical technique and thrombolytic therapy may help improve clinical outcomes, a phase II trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5660762 Sun, 05 Feb 2012 20:19:06 +0100 5660762 http://www.medworm.com/index.php?rid=5649702&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FMHNCS%2F30912 PHOENIX (MedPage Today) -- Patients with advanced nasopharyngeal carcinoma achieved favorable overall survival when bevacizumab was added to upfront and adjuvant therapy, results of a preliminary cooperative group trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5649702 Mon, 30 Jan 2012 15:03:13 +0100 5649702 http://www.medworm.com/index.php?rid=5621104&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FMGICS%2F30804 SAN FRANCISCO (MedPage Today) -- Non-surgical therapies for stage 0-IA squamous esophageal cancer may be a viable alternative treatment that also provides a chance for organ preservation, according to a Japanese study. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5621104 Mon, 23 Jan 2012 22:43:06 +0100 5621104 http://www.medworm.com/index.php?rid=5506553&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASHHematology%2F30201 SAN DIEGO (MedPage Today) -- The investigational monoclonal antibody obinutuzumab (GA101), aimed at non-Hodgkin lymphoma, fared well in a test against rituximab (Rituxan), a researcher reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5506553 Tue, 13 Dec 2011 19:48:47 +0100 5506553 http://www.medworm.com/index.php?rid=5506554&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASHHematology%2F30199 SAN DIEGO (MedPage Today) -- Bone complications in Gaucher disease are similar to those seen in multiple myeloma and may result in missed or delayed diagnosis of the cancer, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5506554 Tue, 13 Dec 2011 19:24:32 +0100 5506554 http://www.medworm.com/index.php?rid=5488264&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FPediatrics%2FGeneralPediatrics%2F30110 (MedPage Today) -- Children born to mothers who develop postpartum depression appear to be more likely than other kids to be diagnosed with a psychiatric disorder by age 6, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5488264 Fri, 09 Dec 2011 16:00:00 +0100 5488264 http://www.medworm.com/index.php?rid=5488265&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASHP%2F30101 NEW ORLEANS (MedPage Today) -- A program that included pharmacists in the discharge process at a medical-surgical unit led to a significant decline in the number of medication errors, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5488265 Thu, 08 Dec 2011 21:00:00 +0100 5488265 http://www.medworm.com/index.php?rid=5477819&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASHP%2F30044 NEW ORLEANS (MedPage Today) -- The routine administration of opioid analgesics after abdominal hysterectomy is associated with a significant increase in the length of hospital stay and substantially high costs, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5477819 Tue, 06 Dec 2011 17:22:37 +0100 5477819 http://www.medworm.com/index.php?rid=5470101&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAdditionalMeetings%2F30003 (MedPage Today) -- Factors that occur during fetal development may help identify offspring -- particularly females -- who are susceptible to the co-occurrence of major depression and cardiovascular disease in mid-life, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5470101 Sun, 04 Dec 2011 11:13:06 +0100 5470101 http://www.medworm.com/index.php?rid=5401569&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASN%2F29627 PHILADELPHIA (MedPage Today) -- From 10% to 15% of patients with chronic kidney disease reported using potentially nephrotoxic dietary supplements, an analysis of a large government database showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5401569 Sat, 12 Nov 2011 20:00:00 +0100 5401569 http://www.medworm.com/index.php?rid=5389498&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACAAI%2F29563 BOSTON (MedPage Today) -- If there's a limit to the range of ways in which the human body can fail, medical science has yet to find it, and allergists may be more aware of that fact than clinicians in other specialties, as this assortment of weird cases illustrates. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5389498 Wed, 09 Nov 2011 21:31:47 +0100 5389498 http://www.medworm.com/index.php?rid=5389499&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACAAI%2F29557 BOSTON (MedPage Today) -- Intradermal allergen testing adds no useful information when evaluating patients for cat allergies, since the results are usually false when they contradict those of skin-prick testing, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5389499 Wed, 09 Nov 2011 20:01:47 +0100 5389499 http://www.medworm.com/index.php?rid=5389500&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACAAI%2F29542 BOSTON (MedPage Today) -- Oral desensitization therapy for severe peanut allergy is feasible in clinical practice as long as patients are counseled appropriately and precautions are rigorously observed, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5389500 Wed, 09 Nov 2011 14:21:58 +0100 5389500 http://www.medworm.com/index.php?rid=5389501&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACAAI%2F29521 BOSTON (MedPage Today) -- New corticosteroid nasal sprays that come in propellant-driven, metered-dose devices for relieving chronic allergic rhinitis may make this treatment approach more acceptable to at least some patients, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5389501 Tue, 08 Nov 2011 21:28:25 +0100 5389501 http://www.medworm.com/index.php?rid=5349457&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECTRIMS%2F29299 AMSTERDAM (MedPage Today) -- The investigational oral drug teriflunomide (Aubagio) seems to have maintained its effectiveness during up to nine years of follow-up in clinical trial patients with the relapsing form of multiple sclerosis, and no late safety problems have been noticed, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5349457 Wed, 26 Oct 2011 23:42:49 +0100 5349457 http://www.medworm.com/index.php?rid=5349458&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCHEST%2F29293 HONOLULU (MedPage Today) -- Sildenafil (Revatio), already approved for pulmonary arterial hypertension on the basis of studies in adults, appears to have some benefits for pediatric patients, a randomized trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5349458 Wed, 26 Oct 2011 18:21:38 +0100 5349458 http://www.medworm.com/index.php?rid=5349459&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCHEST%2F29289 HONOLULU (MedPage Today) -- For patients with severe or difficult-to-treat asthma, as exacerbation severity increased, quality of life suffered, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5349459 Wed, 26 Oct 2011 17:02:15 +0100 5349459 http://www.medworm.com/index.php?rid=5349460&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCHEST%2F29274 HONOLULU (MedPage Today) -- The type of injury sustained by U.S. military personnel in the Middle East appears to be related to the types of sleep disturbances they experience when they return home, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5349460 Wed, 26 Oct 2011 13:01:00 +0100 5349460 http://www.medworm.com/index.php?rid=5349461&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCHEST%2F29269 HONOLULU (MedPage Today) -- A specific airway abnormality may be an objective marker for autism spectrum disorders in children, a small study showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5349461 Tue, 25 Oct 2011 20:19:11 +0100 5349461 http://www.medworm.com/index.php?rid=5337770&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECTRIMS%2F29181 AMSTERDAM (MedPage Today) -- With one exception, the investigational oral drug laquinimod was more effective than placebo, and possibly better than interferon-beta-1a (Avonex), in reducing clinically relevant aspects of multiple sclerosis, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5337770 Sat, 22 Oct 2011 15:25:51 +0100 5337770 http://www.medworm.com/index.php?rid=5337771&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECTRIMS%2F29173 AMSTERDAM (MedPage Today) -- A low-dose regimen of the leukemia drug alemtuzumab (Lemtrada) slashed annualized relapse rates in patients with newly diagnosed multiple sclerosis in a head-to-head trial against interferon-beta-1a (Rebif), a researcher reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5337771 Sat, 22 Oct 2011 07:15:00 +0100 5337771 http://www.medworm.com/index.php?rid=5337772&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECTRIMS%2F29151 AMSTERDAM (MedPage Today) -- Injections of botulinum toxin A (Botox) were a significant help to multiple sclerosis patients whose disease causes arm tremors, according to a small study reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5337772 Thu, 20 Oct 2011 21:54:49 +0100 5337772 http://www.medworm.com/index.php?rid=5337773&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECTRIMS%2F29144 AMSTERDAM (MedPage Today) -- MRI scans taken one year after starting disease-modifying therapy in relapsing-remitting multiple sclerosis were strongly predictive of outcomes after five years, an Italian researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5337773 Thu, 20 Oct 2011 18:47:19 +0100 5337773 http://www.medworm.com/index.php?rid=5324871&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29091 BOSTON (MedPage Today) -- Breastfeeding and immunization protect babies against sudden infant death syndrome but bumper pads don't, according to updated guidelines from the American Academy of Pediatrics. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5324871 Tue, 18 Oct 2011 13:13:07 +0100 5324871 http://www.medworm.com/index.php?rid=5324872&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29092 BOSTON (MedPage Today) -- Babies and toddlers should learn and get their entertainment from play, not from TV screens, computer displays, or video games, according to a new policy statement from the American Academy of Pediatrics. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5324872 Tue, 18 Oct 2011 04:01:00 +0100 5324872 http://www.medworm.com/index.php?rid=5324873&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29075 BOSTON (MedPage Today) -- An unexplained increase in revision circumcisions has pediatric urologists wondering whether the finding is real and, if so, what caused it. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5324873 Mon, 17 Oct 2011 15:17:30 +0100 5324873 http://www.medworm.com/index.php?rid=5324874&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29070 BOSTON (MedPage Today) -- A majority of sudden infant deaths involved unsafe sleeping conditions, suggesting that key messages in sleeping awareness campaigns fail to reach some parents, investigators reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5324874 Mon, 17 Oct 2011 04:01:00 +0100 5324874 http://www.medworm.com/index.php?rid=5324875&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29069 BOSTON (MedPage Today) -- The incidence of knee injuries in children and adolescents has increased dramatically in recent years, according to one large, single-center's clinical experience. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5324875 Sun, 16 Oct 2011 19:08:09 +0100 5324875 http://www.medworm.com/index.php?rid=5316734&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29057 BOSTON (MedPage Today) -- More than half of all hospital psychiatry visits by underinsured pediatric patients came in through the emergency department, investigators reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5316734 Sat, 15 Oct 2011 13:43:10 +0100 5316734 http://www.medworm.com/index.php?rid=5297995&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FOBESITY%2F28942 ORLANDO (MedPage Today) -- Replacing calorie-laden beverages with water or diet drinks may be effective at shedding weight and improving other cardiometabolic parameters in the short term, a randomized trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5297995 Fri, 07 Oct 2011 18:47:18 +0100 5297995 http://www.medworm.com/index.php?rid=5287139&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FOBESITY%2F28889 ORLANDO (MedPage Today) -- Meals offered by the National School Lunch Program appear to be healthier than those packed at home, a study of second graders showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5287139 Wed, 05 Oct 2011 14:21:09 +0100 5287139 http://www.medworm.com/index.php?rid=5287140&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FOBESITY%2F28866 ORLANDO (MedPage Today) -- Mothers of young children get less exercise than women who do not have children at home, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5287140 Tue, 04 Oct 2011 15:59:37 +0100 5287140 http://www.medworm.com/index.php?rid=5275300&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FOBESITY%2F28841 ORLANDO (MedPage Today) -- Stepping up the intensity of a weight-loss intervention only for those patients who fail to reach their goal may be a viable alternative to standard lifestyle approaches, a randomized trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5275300 Mon, 03 Oct 2011 10:43:03 +0100 5275300 http://www.medworm.com/index.php?rid=5275301&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FSurgery%2FOrthopedics%2F28833 (MedPage Today) -- Screening for deep venous thrombosis or pulmonary embolism with duplex ultrasonography is unnecessary after knee or hip arthroplasty, according to a revised clinical practice guidance from the American Academy of Orthopedic Surgeons. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5275301 Sat, 01 Oct 2011 19:00:00 +0100 5275301 http://www.medworm.com/index.php?rid=5239574&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FICAACMeeting%2F28645 CHICAGO (MedPage Today) -- Antibiotic-resistant pathogens born in hospitals may enter the wider environment through the facilities' sewers, although the magnitude of the danger remains unclear, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5239574 Wed, 21 Sep 2011 17:00:00 +0100 5239574 http://www.medworm.com/index.php?rid=5239575&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FICAACMeeting%2F28637 CHICAGO (MedPage Today) -- Vaccine protection against pertussis may wane sharply for children more than three years after their last booster, potentially leaving some middle-schoolers at risk for the disease, a researcher reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5239575 Wed, 21 Sep 2011 14:00:00 +0100 5239575 http://www.medworm.com/index.php?rid=5239576&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FICAACMeeting%2F28615 CHICAGO (MedPage Today) -- An investigational drug for influenza that targets a host-cell factor necessary for infection reduced viral loads by more than 100-fold in a randomized trial, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5239576 Tue, 20 Sep 2011 13:30:00 +0100 5239576 http://www.medworm.com/index.php?rid=5185372&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28296 PARIS (MedPage Today) -- Teaching children to adopt a healthier lifestyle may influence their parents to do the same, a study in a single Brazilian private school suggested. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5185372 Wed, 31 Aug 2011 17:00:00 +0100 5185372 http://www.medworm.com/index.php?rid=5185373&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28294 PARIS (MedPage Today) -- An investigational oral direct factor Xa inhibitor -- darexaban -- increased bleeding in patients with acute coronary syndromes, a phase II study showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5185373 Wed, 31 Aug 2011 15:00:00 +0100 5185373 http://www.medworm.com/index.php?rid=5185374&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28278 PARIS (MedPage Today) -- Among patients who undergo revascularization using stents, prolonging dual antiplatelet therapy beyond six months may not be beneficial, the randomized PRODIGY trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5185374 Tue, 30 Aug 2011 17:50:05 +0100 5185374 http://www.medworm.com/index.php?rid=5185375&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28273 PARIS (MedPage Today) -- Compared with in-office monitoring, patients who have their ICDs monitored remotely had fewer inappropriate shocks, researchers here said. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5185375 Tue, 30 Aug 2011 17:04:00 +0100 5185375 http://www.medworm.com/index.php?rid=5171105&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28254 PARIS (MedPage Today) -- An investigational cholesteryl ester transfer protein (CETP) inhibitor, dalcetrapib, raised HDL cholesterol without any safety concerns in phase IIb dal-VESSEL trial, but it remains to be seen whether that boost in HDL will improve clinical outcomes. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5171105 Mon, 29 Aug 2011 16:43:04 +0100 5171105 http://www.medworm.com/index.php?rid=5171106&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28253 PARIS (MedPage Today) -- Patients with severe heart failure and mitral regurgitation who are not responding to cardiac resynchronization therapy (CRT) significantly improved with a percutaneously inserted mitral valve clip, a small observational study found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5171106 Mon, 29 Aug 2011 15:58:11 +0100 5171106 http://www.medworm.com/index.php?rid=5171107&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28252 PARIS (MedPage Today) -- The combination of two classes of angiotensin inhibitors markedly reduces the risk of atrial fibrillation and also reduces the size of enlarged heart chambers, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5171107 Mon, 29 Aug 2011 15:56:03 +0100 5171107 http://www.medworm.com/index.php?rid=5171108&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28243 PARIS (MedPage Today) -- New research suggests that patients with cardiovascular disease who have unresolved anger problems may find themselves vulnerable for recurrent heart attacks. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5171108 Sun, 28 Aug 2011 19:30:46 +0100 5171108 http://www.medworm.com/index.php?rid=5171109&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28242 PARIS (MedPage Today) -- The anti-inflammatory drug colchicine helped to quickly relieve symptoms related to recurrent pericarditis and reduced the number of further recurrences, a multicenter randomized controlled trial found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5171109 Sun, 28 Aug 2011 17:52:35 +0100 5171109 http://www.medworm.com/index.php?rid=5164192&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28228 PARIS (MedPage Today) -- By the numbers, the European Society of Cardiology meeting is the largest cardiology meeting in the world -- more than 30,800 registrants, representing 154 countries, who will have the opportunity to hear and see findings from 4,276 studies. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5164192 Sat, 27 Aug 2011 17:13:04 +0100 5164192 http://www.medworm.com/index.php?rid=5164193&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FESCCongress%2F28227 PARIS (MedPage Today) -- Despite a dearth of prospective, randomized data, the European Society of Cardiology has released guidelines for the management of cardiovascular disease during pregnancy. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5164193 Sat, 27 Aug 2011 16:42:46 +0100 5164193 http://www.medworm.com/index.php?rid=5053994&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FIASMeeting%2F27694 ROME (MedPage Today) -- The mood at the 2011 meeting of the International AIDS Society has been excited and optimistic. MedPage Today North American correspondent Michael Smith and contributing writer Ed Susman look at why. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5053994 Sat, 23 Jul 2011 18:13:04 +0100 5053994 http://www.medworm.com/index.php?rid=5000329&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMultiMedia%2FMultiMedia%2F27183 (MedPage Today) -- "Conversations with …" is a series of exclusive video interviews with leaders of medical research and policy. In this segment, MedPage Today Editor-at-Large George Lundberg, MD, talks with the new Executive Vice President and CEO of the AMA James L. Madara, MD. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=5000329 Wed, 06 Jul 2011 16:43:02 +0100 5000329 http://www.medworm.com/index.php?rid=4994511&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMultiMedia%2FMultiMedia%2F27183 (MedPage Today) -- "Conversations with …" is a series of exclusive video interviews with leaders of medical research and policy. In this segment, MedPage Today Editor-at-Large George Lundberg, MD, talks with the new Executive Vice President and CEO of the AMA James L. Madara, MD. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4994511 Mon, 04 Jul 2011 13:43:04 +0100 4994511 http://www.medworm.com/index.php?rid=4978520&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FADAMeeting%2F27340 SAN DIEGO (MedPage Today) -- Insulin pumps that automatically shut down when blood glucose hits a certain low level decrease the amount of time pediatric patients spend in hypoglycemia, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4978520 Wed, 29 Jun 2011 19:13:05 +0100 4978520 http://www.medworm.com/index.php?rid=4978521&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FADAMeeting%2F27351 SAN DIEGO (MedPage Today) -- Training people with diabetes to teach other patients improves utilization of medications and results in lifestyle changes -- and also brings long-term benefits, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4978521 Wed, 29 Jun 2011 18:28:38 +0100 4978521 http://www.medworm.com/index.php?rid=4987301&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMultiMedia%2FMultiMedia%2F27182 (MedPage Today) -- "Conversations with ..." is a series of exclusive video interviews with leaders of medical research and policy. In this segment, George Lundberg, MD, MedPage Today Editor-at-Large, talks with Jeremy A. Lazarus, MD, the new president-elect of the AMA, about the Affordable Care Act and accountable care organizations. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4987301 Wed, 29 Jun 2011 16:53:51 +0100 4987301 http://www.medworm.com/index.php?rid=4978522&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMultiMedia%2FMultiMedia%2F27182 (MedPage Today) -- "Conversations with ..." is a series of exclusive video interviews with leaders of medical research and policy. In this segment, George Lundberg, MD, MedPage Today Editor-at-Large, talks with Jeremy A. Lazarus, MD, the new president-elect of the AMA, about the Affordable Care Act and accountable care organizations. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4978522 Wed, 29 Jun 2011 16:53:51 +0100 4978522 http://www.medworm.com/index.php?rid=4971473&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FADAMeeting%2F27304 SAN DIEGO (MedPage Today) -- An antigen-based immunotherapy has failed to halt the progression of type 1 diabetes after one year, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4971473 Mon, 27 Jun 2011 21:43:04 +0100 4971473 http://www.medworm.com/index.php?rid=4971474&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEUROPACE%2F27300 MADRID (MedPage Today) -- Many patients who have unexplained syncope may be undergoing excessive testing before receiving an implantable loop recorder, delaying diagnosis and increasing cost, a researcher suggested here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4971474 Mon, 27 Jun 2011 19:43:20 +0100 4971474 http://www.medworm.com/index.php?rid=4962397&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEUROPACE%2F27242 MADRID (MedPage Today) -- Atrial fibrillation will be one of the primary focuses of this year's EHRA EUROPACE, the meeting of the European Heart Rhythm Association, according to the chair of the scientific program. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4962397 Fri, 24 Jun 2011 15:43:03 +0100 4962397 http://www.medworm.com/index.php?rid=4947290&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAMA%2F27154 CHICAGO (MedPage Today) -- As the constitutionality of the individual mandate is debated in the nation's courts, the issue has emerged as a lightning rod in the American Medical Association's annual House of Delegates meeting here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4947290 Mon, 20 Jun 2011 19:43:04 +0100 4947290 http://www.medworm.com/index.php?rid=4939394&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAdditionalMeetings%2F27133 (MedPage Today) -- A drug-eluting stent for the superficial femoral artery showed sustained effectiveness at two years in diabetics versus nondiabetics, a substudy found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4939394 Sat, 18 Jun 2011 18:43:03 +0100 4939394 http://www.medworm.com/index.php?rid=4939395&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAdditionalMeetings%2F27130 (MedPage Today) -- Anticoagulation for deep vein thrombosis in the calf reduces the risk that the clot will propagate and may improve other clinical outcomes as well, according to a meta-analysis. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4939395 Sat, 18 Jun 2011 15:23:00 +0100 4939395 http://www.medworm.com/index.php?rid=4924464&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASE%2F27047 MONTREAL (MedPage Today) -- Diastolic function assessed using speckle-tracking echocardiography is predictive of all-cause mortality in patients with acute coronary syndromes, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4924464 Mon, 13 Jun 2011 22:43:04 +0100 4924464 http://www.medworm.com/index.php?rid=4915146&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26995 CHICAGO (MedPage Today) -- Maintenance therapy with pemetrexed (Alimta) appears to significantly extend progression-free survival in advanced lung cancer patients, although the difference when compared with placebo is modest. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4915146 Fri, 10 Jun 2011 17:43:05 +0100 4915146 http://www.medworm.com/index.php?rid=4915147&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26985 CHICAGO (MedPage Today) -- Despite being heavily pretreated, advanced multiple myeloma patients appear to achieve a substantial benefit when treated with the investigational agent pomalidomide, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4915147 Fri, 10 Jun 2011 17:30:00 +0100 4915147 http://www.medworm.com/index.php?rid=4905204&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26894 (MedPage Today) -- CHICAGO -– Treatment with zoledronic acid (Zometa) significantly reduced skeletal-related events in patients with multiple myeloma, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905204 Tue, 07 Jun 2011 18:13:05 +0100 4905204 http://www.medworm.com/index.php?rid=4905205&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FENDO%2F26897 BOSTON (MedPage Today) -- Women who have higher levels of endogenous estrogen before starting hormone therapy appear to have a lower risk of heart disease, according to a subgroup analysis of the Women's Health Initiative (WHI) data reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905205 Tue, 07 Jun 2011 17:00:00 +0100 4905205 http://www.medworm.com/index.php?rid=4905206&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26888 MONTREAL (MedPage Today) -- Genetic analysis of a Canadian family with an extraordinarily high prevalence of multiple sclerosis suggested that a rogue tyrosine kinase may play a role in causing the disease, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905206 Tue, 07 Jun 2011 16:00:00 +0100 4905206 http://www.medworm.com/index.php?rid=4905207&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26889 MONTREAL (MedPage Today) -- A common retinal imaging technology could eventually supplement or even replace MRI scans for tracking multiple sclerosis severity and progression, researchers suggested here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905207 Tue, 07 Jun 2011 15:00:00 +0100 4905207 http://www.medworm.com/index.php?rid=4905208&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26873 MONTREAL (MedPage Today) -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, although the effect on relapse rates was less clear, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905208 Mon, 06 Jun 2011 18:10:16 +0100 4905208 http://www.medworm.com/index.php?rid=4905209&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26859 MONTREAL (MedPage Today) -- Younger age, faster diagnosis, and undergoing treatment in Europe were among the factors associated with greater likelihood of survival in cases of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients treated with natalizumab (Tysabri), a researcher reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4905209 Mon, 06 Jun 2011 14:00:00 +0100 4905209 http://www.medworm.com/index.php?rid=4896648&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26850 MONTREAL (MedPage Today) -- Starting interferon-beta-1a (Rebif New Formulation) immediately upon an episode of a clinically isolated syndrome delayed progression to full-blown multiple sclerosis, but once-weekly treatment was less effective than the standard dosing interval, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4896648 Sun, 05 Jun 2011 13:01:00 +0100 4896648 http://www.medworm.com/index.php?rid=4896649&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26851 MONTREAL (MedPage Today) -- Several short, noncoding RNA molecules are associated with multiple sclerosis symptoms, perhaps in enough of a causal way to become therapeutic targets as well as biomarkers of disease, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4896649 Sat, 04 Jun 2011 21:31:00 +0100 4896649 http://www.medworm.com/index.php?rid=4896650&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FCMSC%2F26848 MONTREAL (MedPage Today) -- Months or even years before demyelinating events are recognized, patients later diagnosed with multiple sclerosis often turn up in their doctors' offices complaining of fatigue, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4896650 Sat, 04 Jun 2011 21:06:26 +0100 4896650 http://www.medworm.com/index.php?rid=4886710&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEULAR%2F26790 LONDON (MedPage Today) -- Treatment with interleukin-6 receptor blocker tocilizumab (Acterma) appears safe in patients with rheumatoid arthritis whose disease has progressed on other advanced therapies, according to research here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4886710 Wed, 01 Jun 2011 15:30:00 +0100 4886710 http://www.medworm.com/index.php?rid=4886711&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEULAR%2F26787 LONDON (MedPage Today) -- The interleukin-1 inhibitor rilonacept (Arcalyst) can help prevent the flares of gout that often occur during the first few months of uric acid-lowering therapy, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4886711 Wed, 01 Jun 2011 14:30:00 +0100 4886711 http://www.medworm.com/index.php?rid=4886712&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FPrimaryCare%2FDietNutrition%2F26786 (MedPage Today) -- A low-carbohydrate diet didn't lead to harder arteries, at least not in the short term, researchers found, nor did a single fatty meal. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4886712 Wed, 01 Jun 2011 04:01:00 +0100 4886712 http://www.medworm.com/index.php?rid=4886713&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEULAR%2F26769 LONDON (MedPage Today) -- Patients with systemic lupus erythematosus who have persistent disease activity are at risk for organ damage and mortality, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4886713 Tue, 31 May 2011 19:30:00 +0100 4886713 http://www.medworm.com/index.php?rid=4874032&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FEULAR%2F26743 LONDON (MedPage Today) -- Rheumatoid arthritis patients who were seropositive -- particularly for anti-cyclic citrullinated peptide (CCP) antibodies -- responded better to treatment with abatacept (Orencia) than patients without the antibodies, according to five-year registry data. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4874032 Sat, 28 May 2011 19:43:04 +0100 4874032 http://www.medworm.com/index.php?rid=4874033&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEULAR%2F26758 LONDON (MedPage Today) -- Rheumatoid arthritis patients initially treated with tumor necrosis factor inhibitor adalimumab (Humira) plus disease-modifying methotrexate, maintained improved disease control over eight years compared with patients who began monotherapy, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4874033 Sat, 28 May 2011 13:00:00 +0100 4874033 http://www.medworm.com/index.php?rid=4855335&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAPA%2F26653 HONOLULU (MedPage Today) -- The forthcoming fifth edition of the psychiatric profession's primary diagnostic manual will not only harmonize with the ICD-11 international disease coding system now in development, but also with global psychiatry in general, says a top APA official. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4855335 Tue, 24 May 2011 14:30:00 +0100 4855335 http://www.medworm.com/index.php?rid=4833190&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAUAMeeting%2F26554 WASHINGTON (MedPage Today) -- Use of radical nephrectomy for small renal masses remains "alarmingly high," especially among older patients, kidney cancer specialists reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833190 Wed, 18 May 2011 20:13:05 +0100 4833190 http://www.medworm.com/index.php?rid=4833191&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAPA%2F26546 HONOLULU (MedPage Today) -- Children of active-duty soldiers may be at greater risk of being hospitalized for a psychiatric illness, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833191 Wed, 18 May 2011 18:00:00 +0100 4833191 http://www.medworm.com/index.php?rid=4833192&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEuroPCR%2F26551 PARIS (MedPage Today) -- A femoral artery closure device may reduce large hematomas and speed closure compared with manual compression of the catheter access wound, a randomized trial indicated. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833192 Wed, 18 May 2011 16:04:45 +0100 4833192 http://www.medworm.com/index.php?rid=4833193&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FATS%2F26533 DENVER (MedPage Today) -- Nearly a third of parents whose children have asthma are not getting them vaccinated against the flu, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833193 Wed, 18 May 2011 15:23:30 +0100 4833193 http://www.medworm.com/index.php?rid=4833194&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAPA%2F26544 HONOLULU (MedPage Today) -- Lithium carbonate added to guideline-directed mood stabilizer therapy for bipolar disorder provided little benefit but increased the adverse effects in a major trial, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833194 Wed, 18 May 2011 15:00:00 +0100 4833194 http://www.medworm.com/index.php?rid=4833195&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FATS%2F26539 DENVER (MedPage Today) -- An enzyme involved in atherosclerosis may play a protective role in asthma, at least in women, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833195 Wed, 18 May 2011 13:30:00 +0100 4833195 http://www.medworm.com/index.php?rid=4833196&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAPA%2F26519 HONOLULU (MedPage Today) -- Despite a dire need for better therapies, the pharmaceutical pipeline for psychiatric drugs is dwindling, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4833196 Tue, 17 May 2011 17:00:00 +0100 4833196 http://www.medworm.com/index.php?rid=4814931&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAPA%2F26445 HONOLULU (MedPage Today) -- The process of revising the Diagnostic and Statistical Manual of Mental Disorders -- the "psychiatrist's bible" -- remains firmly on schedule for its official release in 2013, according to the leader of the effort. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4814931 Thu, 12 May 2011 20:13:03 +0100 4814931 http://www.medworm.com/index.php?rid=4798915&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FDDW%2F26362 CHICAGO (MedPage Today) -- The biologic adalimumab (Humira) actively, but safely, crosses the placenta in pregnant women with inflammatory bowel disease (IDB), and can be detected in neonatal serum for at least three months, a researcher reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798915 Mon, 09 May 2011 13:43:04 +0100 4798915 http://www.medworm.com/index.php?rid=4798916&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FDDW%2F26368 CHICAGO (MedPage Today) -- Medication adherence in children with inflammatory bowel disease appeared to be no better than about 50% in a bottle cap-tracking study, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798916 Mon, 09 May 2011 11:30:00 +0100 4798916 http://www.medworm.com/index.php?rid=4798918&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26366 SAN FRANCISCO (MedPage Today) -- Large differences exist between primary and specialty care in warfarin treatment after new-onset atrial fibrillation, possibly signifying a quality gap, according to TREAT-AF investigators. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798918 Mon, 09 May 2011 09:00:00 +0100 4798918 http://www.medworm.com/index.php?rid=4798917&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSID%2F26363 PHOENIX (MedPage Today) -- Calcium and vitamin D supplementation did not reduce the overall incidence of nonmelanoma skin cancer (NMSC) in women, although those with a history of NMSC did see a 57% risk reduction for melanoma, a post-hoc analysis of a large clinical trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798917 Mon, 09 May 2011 09:00:00 +0100 4798917 http://www.medworm.com/index.php?rid=4798919&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSID%2F26365 PHOENIX (MedPage Today) -- Half of patients with mild or moderate plaque psoriasis had significantly greater lesion improvement when treated with a boron-based, topical anti-inflammatory agent compared with an inert ointment, data from a randomized trial showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798919 Sun, 08 May 2011 23:02:22 +0100 4798919 http://www.medworm.com/index.php?rid=4798921&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26357 SAN FRANCISCO (MedPage Today) -- A program that screened all students at a Chicago-area school for heart problems was clinically successful, but drew criticism for its broad scope and expected costs. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798921 Sun, 08 May 2011 21:00:00 +0100 4798921 http://www.medworm.com/index.php?rid=4798920&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FDDW%2F26360 CHICAGO (MedPage Today) -- An investigational acetylcholinesterase inhibitor called acotiamide significantly reduced dyspepsia symptoms in a phase III trial, it was reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798920 Sun, 08 May 2011 21:00:00 +0100 4798920 http://www.medworm.com/index.php?rid=4798922&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26358 SAN FRANCISCO (MedPage Today) -- Electrical stimulation in patients with Brugada syndrome is not predictive of cardiac events, but researchers identified new risk indicators that could better triage higher risk patients to receive implantable defibrillation therapy. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798922 Sun, 08 May 2011 19:00:00 +0100 4798922 http://www.medworm.com/index.php?rid=4798923&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26359 SAN FRANCISCO (MedPage Today) -- Point ablation of atrial fibrillation triggers outside the pulmonary vein may actually worsen outcomes if done by a low-power, automated selection process, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4798923 Sun, 08 May 2011 16:41:52 +0100 4798923 http://www.medworm.com/index.php?rid=4791111&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSID%2F26329 PHOENIX (MedPage Today) -- Mycosis fungoides lesions improved quickly and extensively in 15 of 16 patients enrolled in a small clinical trial of low-dose total skin electron beam therapy. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4791111 Fri, 06 May 2011 18:43:03 +0100 4791111 http://www.medworm.com/index.php?rid=4791112&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FDDW%2F26323 CHICAGO (MedPage Today) -- Screening children as young as 2 years for obesity may be more successful in weight control and preventing metabolic abnormalities than waiting until they are older, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4791112 Fri, 06 May 2011 17:00:00 +0100 4791112 http://www.medworm.com/index.php?rid=4791113&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26324 SAN FRANCISCO (MedPage Today) -- Bowling alleys, dance studios, and other places people exert themselves outside the gym shouldn't be overlooked in rolling out automated external defibrillators, researchers warned. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4791113 Fri, 06 May 2011 16:32:16 +0100 4791113 http://www.medworm.com/index.php?rid=4791114&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSCAI%2F26322 BALTIMORE (MedPage Today) -- Very few of the readmissions within 30 days of a percutaneous coronary intervention (PCI) can be tracked back to the procedure itself, data from a single healthcare system showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4791114 Fri, 06 May 2011 16:25:22 +0100 4791114 http://www.medworm.com/index.php?rid=4783805&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26302 SAN FRANCISCO (MedPage Today) -- Avoiding a break in anticoagulation for cardiac device implantation may be safe for high-risk patients and get them home sooner with fewer complications, a single-center registry suggested. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4783805 Thu, 05 May 2011 18:13:04 +0100 4783805 http://www.medworm.com/index.php?rid=4783806&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26303 SAN FRANCISCO (MedPage Today) -- The use of catheter ablation for atrial fibrillation has skyrocketed in the last few years, and for good reason. It works, as far as studies have shown, but more studies are needed to fill in crucial knowledge gaps, according to a presentation here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4783806 Thu, 05 May 2011 16:39:41 +0100 4783806 http://www.medworm.com/index.php?rid=4783807&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26298 SAN FRANCISCO (MedPage Today) -- A novel cardioverter-defibrillator implanted just beneath the skin without the traditional lead wires into the heart remains promising even after longer clinical experience, Dutch researchers reported. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4783807 Thu, 05 May 2011 15:21:30 +0100 4783807 http://www.medworm.com/index.php?rid=4783808&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FLWPES%2F26289 DENVER (MedPage Today) -- Premature babies tend to grow in a normal manner but -- at least through 4 years of age -- do not catch up in height and weight with their full-term peers, Dutch researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4783808 Thu, 05 May 2011 14:08:23 +0100 4783808 http://www.medworm.com/index.php?rid=4783809&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FOphthalmology%2FGlaucoma%2F26271 (MedPage Today) -- An investigational, once-daily drug called tafluprost appears to lower intraocular pressure at least as well as a twice-daily glaucoma drug, researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4783809 Wed, 04 May 2011 16:00:00 +0100 4783809 http://www.medworm.com/index.php?rid=4772196&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FNKF%2F26227 LAS VEGAS (MedPage Today) -- Rhabdomyolysis, a rare muscle condition that can have a serious impact on kidney function, has been reported as an outcome of a hazing ritual in which a college student was beaten hundreds of times with paddles. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4772196 Mon, 02 May 2011 18:13:01 +0100 4772196 http://www.medworm.com/index.php?rid=4772197&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHRS%2F26226 SAN FRANCISCO (MedPage Today) -- Innovation and disruptive technology will headline the Heart Rhythm Society meeting here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4772197 Mon, 02 May 2011 16:23:28 +0100 4772197 http://www.medworm.com/index.php?rid=4768988&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FNKF%2F26213 LAS VEGAS (MedPage Today) -- Patients with chronic kidney disease were less likely to visit the dentist, possibly increasing the burden of their disease, researchers reported at the National Kidney Foundation Spring Clinical Meetings. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4768988 Sun, 01 May 2011 15:43:05 +0100 4768988 http://www.medworm.com/index.php?rid=4768989&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FPAS%2F26210 DENVER (MedPage Today) -- A woman's exposure to certain solvent compounds was associated with a heightened risk for congenital heart disease in her offspring, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4768989 Sat, 30 Apr 2011 18:13:04 +0100 4768989 http://www.medworm.com/index.php?rid=4768990&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FNKF%2F26209 LAS VEGAS (MedPage Today) -- Patient care at dialysis clinics appears to be similar in urban and suburban areas, according to a report at the National Kidney Foundation Spring Clinical Meetings. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4768990 Sat, 30 Apr 2011 18:12:13 +0100 4768990 http://www.medworm.com/index.php?rid=4768991&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FCardiology%2FPrevention%2F26207 (MedPage Today) -- Fatty acids in the blood from a too-rich diet or metabolic disorders may interfere with aspirin's cardiovascular protection, researchers warned. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4768991 Sat, 30 Apr 2011 13:00:00 +0100 4768991 http://www.medworm.com/index.php?rid=4764474&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FNKF%2F26202 LAS VEGAS (MedPage Today) -- Lifestyle decisions made before age 30 appear to determine a person's risk of developing chronic kidney disease many years down the road, researchers suggested here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4764474 Fri, 29 Apr 2011 22:13:05 +0100 4764474 http://www.medworm.com/index.php?rid=4764475&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FNKF%2F26198 LAS VEGAS (MedPage Today) -- Women undergoing coronary angiography appear to have an increased risk for radiocontrast-induced nephrotoxicity, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4764475 Fri, 29 Apr 2011 20:28:08 +0100 4764475 http://www.medworm.com/index.php?rid=4727208&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F26018 (MedPage Today) -- BRIGHTON, England -- Early treatment with abatacept (Orencia) plus methotrexate was associated with high rates of disease remission among methotrexate-naive rheumatoid arthritis patients in a two-year multinational study, investigators said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4727208 Wed, 20 Apr 2011 02:13:06 +0100 4727208 http://www.medworm.com/index.php?rid=4727209&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F26015 (MedPage Today) -- BRIGHTON, England -- Polymorphisms in the vascular endothelial growth factor A (VEGFA) gene are associated with the development of cardiovascular complications in patients with rheumatoid arthritis, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4727209 Tue, 19 Apr 2011 17:00:00 +0100 4727209 http://www.medworm.com/index.php?rid=4727210&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F26002 (MedPage Today) -- BRIGHTON, England -- Patients with early inflammatory polyarthritis with positive titers of anti-citrullinated protein antibodies (ACPA) appear to be at high risk for disease progression -- and should be considered potential candidates for biologic therapy, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4727210 Tue, 19 Apr 2011 14:30:00 +0100 4727210 http://www.medworm.com/index.php?rid=4727211&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F25996 (MedPage Today) -- BRIGHTON, England -- The monoclonal antibody canakinumab (Ilaris) provided rapid pain relief in acute flares of gout in patients with difficult-to-treat disease, according to results of a randomized trial reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4727211 Mon, 18 Apr 2011 18:00:00 +0100 4727211 http://www.medworm.com/index.php?rid=4720684&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25965 HONOLULU (MedPage Today) -- Low heart rate and AV block can occur in the first few hours after the initial dose of a new oral multiple sclerosis drug, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4720684 Sat, 16 Apr 2011 21:13:04 +0100 4720684 http://www.medworm.com/index.php?rid=4720685&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25963 HONOLULU (MedPage Today) -- Multiple sclerosis patients had fewer relapses and brain lesions when they were treated in a small trial with a transdermal patch that delivers myelin peptides. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4720685 Fri, 15 Apr 2011 21:03:23 +0100 4720685 http://www.medworm.com/index.php?rid=4720686&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25961 HONOLULU (MedPage Today) -- Multiple sclerosis patients with memory impairment who got l-amphetamine had nearly a 50% improvement on two memory tests, according to research reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4720686 Fri, 15 Apr 2011 20:46:14 +0100 4720686 http://www.medworm.com/index.php?rid=4716252&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAACE%2F25951 SAN DIEGO (MedPage Today) -- Even when they are within the normal range, thyroid hormone levels shortly before childbirth may help predict which women will develop mood disturbances, a Greek study showed. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4716252 Fri, 15 Apr 2011 20:13:02 +0100 4716252 http://www.medworm.com/index.php?rid=4716253&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEuroPRevent%2F25954 GENEVA (MedPage Today) -- Cardiac screening before participating in sports isn't just for the young, according to a study suggesting that runners who take up marathon running in middle age also need examination for risky heart conditions. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4716253 Fri, 15 Apr 2011 18:05:35 +0100 4716253 http://www.medworm.com/index.php?rid=4716254&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEuroPRevent%2F25949 GENEVA (MedPage Today) -- Ventricular assist devices may equal heart transplantation in helping patients get through daily activities, although they don't measure up for relief from breathlessness and restoration of exercise capacity, according to a small study. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4716254 Fri, 15 Apr 2011 16:10:53 +0100 4716254 http://www.medworm.com/index.php?rid=4716255&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25943 HONOLULU (MedPage Today) -- Two more research groups said they couldn't confirm the idea that obstructed veins in the head and neck are responsible for multiple sclerosis. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4716255 Fri, 15 Apr 2011 15:00:00 +0100 4716255 http://www.medworm.com/index.php?rid=4716256&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25935 HONOLULU (MedPage Today) -- Laquinimod, an investigational oral drug for multiple sclerosis, showed relatively modest efficacy in the first of two pivotal trials, but has stirred unusually strong enthusiasm nonetheless. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4716256 Thu, 14 Apr 2011 21:23:12 +0100 4716256 http://www.medworm.com/index.php?rid=4711083&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F25932 (MedPage Today) -- BRIGHTON, England -- Treatment of early arthritis with a combination regimen of methotrexate and the tumor necrosis factor inhibitor adalimumab (Humira) both suppressed inflammation and prevented damage to bone and cartilage, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4711083 Thu, 14 Apr 2011 20:13:02 +0100 4711083 http://www.medworm.com/index.php?rid=4711084&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25931 (MedPage Today) -- In this exclusive InFocus video report, a leading multiple sclerosis researcher explains one reason why some labs see cerebrospinal venous obstructions in most MS patients studied while other groups can't find them in any patients. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4711084 Thu, 14 Apr 2011 19:40:57 +0100 4711084 http://www.medworm.com/index.php?rid=4711085&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F25927 (MedPage Today) -- BRIGHTON, England -- Long-term data continue to confirm the safety of tocilizumab (Actemra) in the treatment of rheumatoid arthritis, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4711085 Thu, 14 Apr 2011 18:51:26 +0100 4711085 http://www.medworm.com/index.php?rid=4711086&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25914 HONOLULU (MedPage Today) -- Multiple sclerosis patients who did aerobic exercise before the onset of their disease tended to experience less brain atrophy later, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4711086 Thu, 14 Apr 2011 00:03:24 +0100 4711086 http://www.medworm.com/index.php?rid=4705893&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F25901 (MedPage Today) -- BRIGHTON, ENGLAND -- New classification criteria for rheumatoid arthritis, jointly proposed by the American College of Rheumatology and the European League Against Rheumatism, allow for earlier diagnosis of the disease -- the time when treatment may have the most impact, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4705893 Wed, 13 Apr 2011 18:13:04 +0100 4705893 http://www.medworm.com/index.php?rid=4705894&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FBSR%2F25900 (MedPage Today) -- BRIGHTON, England -- Treatment with rituximab (Rituxan) in real-world clinical settings was effective for many patients with rheumatoid arthritis, even those who had no benefit from other biologic drugs, the largest observational study to date found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4705894 Wed, 13 Apr 2011 17:38:26 +0100 4705894 http://www.medworm.com/index.php?rid=4705895&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25882 HONOLULU (MedPage Today) -- Relapses and/or disease progression are common among multiple sclerosis patients taking natalizumab (Tysabri) who stop the drug, casting doubt on "drug holidays" as a strategy for minimizing the risk of progressive multifocal leukoencephalopathy, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4705895 Tue, 12 Apr 2011 22:48:27 +0100 4705895 http://www.medworm.com/index.php?rid=4705896&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25877 HONOLULU (MedPage Today) -- Muscle strength and lung function were significantly enhanced in multiple sclerosis patients who participated in a remotely supervised at-home exercise program, a researcher said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4705896 Tue, 12 Apr 2011 19:31:18 +0100 4705896 http://www.medworm.com/index.php?rid=4699416&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAANMeeting%2F25854 HONOLULU (MedPage Today) -- The investigational drug laquinimod, in development for treating relapsing-remitting multiple sclerosis, reduced the relapse rate as well as disease progression in a placebo-controlled phase III trial, according to data released here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4699416 Mon, 11 Apr 2011 21:21:57 +0100 4699416 http://www.medworm.com/index.php?rid=4687781&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25804 NEW ORLEANS (MedPage Today) -- This exclusive InFocus video report looks at the highlights of the American College of Cardiology meeting, where the results from the higher-risk PARTNER trial cohort took center stage, promising a broader scope of practice for interventionalists. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4687781 Fri, 08 Apr 2011 17:43:02 +0100 4687781 http://www.medworm.com/index.php?rid=4687782&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25806 NEW ORLEANS (MedPage Today) -- About one in three lung transplant patients tend to develop post-operative atrial fibrillation -- especially those who have to be put on a heart-lung device during the surgery, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4687782 Fri, 08 Apr 2011 17:07:19 +0100 4687782 http://www.medworm.com/index.php?rid=4687783&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25805 NEW ORLEANS (MedPage Today) -- Atrial flutter ablation treatments were successful in virtually all cases, researchers said here at the annual meeting of the American College of Cardiology. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4687783 Fri, 08 Apr 2011 16:55:11 +0100 4687783 http://www.medworm.com/index.php?rid=4687784&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25803 NEW ORLEANS (MedPage Today) -- Magnetically-guided gold-tipped catheters may prove more successful than first generation devices in ablating persistent atrial fibrillation, researchers suggested here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4687784 Fri, 08 Apr 2011 16:09:19 +0100 4687784 http://www.medworm.com/index.php?rid=4678311&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAACRMeeting%2F25730 ORLANDO (MedPage Today) -- Targeted nanoparticle technology demonstrated its potential as a vehicle for intraperitoneal chemoradiation for ovarian cancer, according to results from a preclinical model presented here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678311 Tue, 05 Apr 2011 22:43:05 +0100 4678311 http://www.medworm.com/index.php?rid=4678312&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25728 NEW ORLEANS (MedPage Today) -- Arterial calcification has been found in ancient Egyptian mummies dating back nearly 4,000 years -- raising questions about humans' predisposition to atherosclerosis, researchers reported here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678312 Tue, 05 Apr 2011 18:16:55 +0100 4678312 http://www.medworm.com/index.php?rid=4678313&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25727 NEW ORLEANS (MedPage Today) -- For patients with triple-vessel disease undergoing CABG, radial artery grafts appear to be less likely than saphenous veins to become occluded in the long term, according to randomized trial. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678313 Tue, 05 Apr 2011 18:14:59 +0100 4678313 http://www.medworm.com/index.php?rid=4678314&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25726 NEW ORLEANS (MedPage Today) -- Use of a simple blood pressure cuff measurement in the office may help separate so-called white coat hypertension from true hypertension, Korean researchers found. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678314 Tue, 05 Apr 2011 18:05:50 +0100 4678314 http://www.medworm.com/index.php?rid=4678315&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25723 NEW ORLEANS (MedPage Today) -- No matter what form of atrial fibrillation a patient has, anticoagulant treatment with oral high-dose dabigatran (Pradaxa) appears to be better than warfarin therapy in preventing stroke or episodes of systemic embolism, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678315 Tue, 05 Apr 2011 17:15:00 +0100 4678315 http://www.medworm.com/index.php?rid=4678316&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACCMeeting%2F25719 NEW ORLEANS (MedPage Today) -- A trial comparing the Impella heart pump and an intra-aortic balloon pump for hemodynamic support during high-risk PCI failed to meet its primary endpoint -- but researchers say the device still holds some promise. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4678316 Tue, 05 Apr 2011 15:00:00 +0100 4678316 http://www.medworm.com/index.php?rid=4659914&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSIRMeeting%2F25645 CHICAGO (MedPage Today) -- Whether drug-eluting stents keep arteriovenous dialysis access open better than angioplasty alone has been called into question by preliminary results of a randomized trial. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4659914 Thu, 31 Mar 2011 17:43:05 +0100 4659914 http://www.medworm.com/index.php?rid=4654935&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPM%2F25627 WASHINGTON (MedPage Today) -- The next big thing in healthcare won't be large, all-purpose healthcare organizations -- it will be 'focused factories' for treating specific problems, a Harvard economist says. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4654935 Wed, 30 Mar 2011 17:43:02 +0100 4654935 http://www.medworm.com/index.php?rid=4646007&cid=s_38007_22_f&fid=38007&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPM%2F25592 WASHINGTON (MedPage Today) -- The type of migraine appears to make a difference in whether onabotulinum toxin A (Botox) can provide symptomatic relief from the debilitating headaches, researchers said here. (Source: MedPage Today Meeting Coverage) MedPage Today Meeting Coverage news http://www.medworm.com/rss/comments.php?id=4646007 Tue, 29 Mar 2011 17:43:02 +0100 4646007